0001181431-13-015380.txt : 20130307 0001181431-13-015380.hdr.sgml : 20130307 20130307165058 ACCESSION NUMBER: 0001181431-13-015380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130305 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Veitch David CENTRAL INDEX KEY: 0001539762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15313 FILM NUMBER: 13674009 MAIL ADDRESS: STREET 1: ONE TOWER CENTER BLVD CITY: EAST BRUNSWICK, NJ STATE: NJ ZIP: 08816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 rrd373196.xml VEITCH FORM 4 X0306 4 2013-03-05 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001539762 Veitch David MESPIL BUSINESS CENTRE MESPIL HOUSE, SUSSEX ROAD DUBLIN 4 L2 IRELAND 0 1 0 0 President Savient Pharma Ireland Limited Option to Purchase Common Stock 0.94 2013-03-05 4 A 0 110000 0 A 2023-03-05 Common Stock 110000 110000 D Option to Purchase Common Stock 0.94 2013-03-05 4 A 0 162500 0 A 2022-01-16 Common Stock 162500 162500 D These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013. These options were granted pursuant to the terms of Mr. Veitch's employment and vest as follows: 25% on the first anniversary of his commencement date, January 16, 2012, and an additional 6.25% at the end of each successive three-month period following the first anniversary, Philip K. Yachmetz as attorney-in-fact for David Veitch 2013-03-07